Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN

Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease

(2017) Jeffrey S. Hyams et al.   GASTROENTEROLOGY

International incidence of childhood cancer, 2001–10: a population-based registry study

(2017) Eva Steliarova-Foucher et al.   LANCET ONCOLOGY

Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014

(2017) O Olén et al.   BMJ-British Medical Journal

Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014

(2017) O Olén et al.   BMJ-British Medical Journal

The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease

(2016) F. Carrat et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis

(2015) David S. Kotlyar et al.   Clinical Gastroenterology and Hepatology

Association Between Thiopurine Use and Nonmelanoma Skin Cancers in Patients With Inflammatory Bowel Disease: A Meta-Analysis

(2014) Jonathan Ariyaratnam et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Mortality and Cancer in Pediatric-Onset Inflammatory Bowel Disease: A Population-Based Study

(2013) Anaïs Peneau et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease

(2013) Lissy de Ridder et al.   INFLAMMATORY BOWEL DISEASES

European evidence based consensus for endoscopy in inflammatory bowel disease

(2013) Vito Annese et al.   Journal of Crohns & Colitis

Trends in Overall and Cause-Specific Mortality Among Patients With Inflammatory Bowel Disease From 1982 to 2010

(2012) Tine Jess et al.   Clinical Gastroenterology and Hepatology

Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project

(2012) Isabelle Cleynen et al.   GUT

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

(2011) Natalie A. Molodecky et al.   GASTROENTEROLOGY

Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease

(2011) Fiona D M van Schaik et al.   GUT

Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease

(2011) L. Peyrin-Biroulet et al.   GUT

Incidence and prevalence of inflammatory bowel disease in children in South-Western Sweden

(2010) H Hildebrand et al.   ACTA PAEDIATRICA

Tumor necrosis factor α blockers and malignancy in children: Forty-eight cases reported to the food and drug administration

(2010) Peter Diak et al.   ARTHRITIS AND RHEUMATISM

Hepatosplenic T-Cell Lymphoma in a Young Man With Crohn's Disease: Case Report and Literature Review

(2010) Mark G. Ochenrider et al.   Clinical Lymphoma Myeloma & Leukemia

Pediatric modification of the Montreal classification for inflammatory bowel disease

(2010) Arie Levine et al.   INFLAMMATORY BOWEL DISEASES

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

(2009) Laurent Beaugerie et al.   LANCET

Disease Behavior in Children with Crohn’s Disease: The Effect of Disease Duration, Ethnicity, Genotype, and Phenotype

(2008) Ron Shaoul et al.   DIGESTIVE DISEASES AND SCIENCES

Definition of Phenotypic Characteristics of Childhood-Onset Inflammatory Bowel Disease

(2008) Johan Van Limbergen et al.   GASTROENTEROLOGY